Welcome to our dedicated page for Philip Morris news (Ticker: PM), a resource for investors and traders seeking the latest updates and insights on Philip Morris stock.
Philip Morris International Inc. reports developments across its cigarette business and expanding smoke-free portfolio, including IQOS heated tobacco products, ZYN nicotine pouches and e-vapor offerings. Company news commonly covers quarterly results, shipment and revenue trends, product authorizations, brand collaborations, and updates tied to adult-smoker alternatives.
Recurring announcements also address U.S. and international regulatory matters, including FDA modified-risk tobacco product authorizations for IQOS, as well as annual shareholder meetings, board elections, executive compensation votes, auditor ratification, shareholder proposals, and corporate responsibility initiatives.
Philip Morris International (NYSE: PM) reported strong Q2 2025 results, with reported diluted EPS growing 26.6% to $1.95 and adjusted diluted EPS increasing 20.1% to $1.91. The company's smoke-free business now accounts for 41% of total net revenues, up 2.9 percentage points year-over-year.
Key highlights include IQOS exceeding $3 billion in quarterly net revenues, ZYN's U.S. offtake growth reaccelerating to 36% in June, and smoke-free product shipment volumes increasing by 11.8%. The company raised its full-year 2025 guidance, now projecting adjusted diluted EPS of $7.43-$7.56, representing 13-15% growth.
Total net revenues reached $10.1 billion, up 7.1% year-over-year, while operating income grew 7.8% to $3.7 billion. The company's smoke-free products are now available in 97 markets, with IQOS maintaining approximately 76% global heat-not-burn category share.
Philip Morris International (NYSE: PM) has announced it will host a live audio webcast to discuss its 2025 second-quarter and first-half results on Tuesday, July 22, 2025, at 9:00 a.m. ET. The results will be released at approximately 7:00 a.m. ET the same day.
The company's smoke-free products are now available in 95 markets with approximately 38.6 million adult users globally. The smoke-free segment represented 42% of PMI's Q1 2025 total net revenues. PMI has invested over $14 billion since 2008 in developing and commercializing smoke-free products, with FDA authorizations for IQOS devices, General snus, and ZYN nicotine pouches.
Philip Morris International (NYSE: PM) has announced it will host a live webcast of its presentation at the 2025 dbAccess Global Consumer Conference. The session will feature CFO Emmanuel Babeau on June 3, 2025, at 11:15 a.m. CET. The company's smoke-free products are now available in 95 markets with approximately 38.6 million adult users globally. The smoke-free segment represented 42% of PMI's Q1 2025 total net revenues. Since 2008, PMI has invested over $14 billion in developing smoke-free products, demonstrating its commitment to a smoke-free future. The company has received FDA authorizations for its IQOS devices, Swedish Match's General snus, and ZYN nicotine pouches.
Philip Morris International (NYSE: PM) held its 2025 Annual Meeting of Shareholders, highlighting significant achievements in its smoke-free transformation. CEO Jacek Olczak reported that the company's smoke-free business reached nearly $15 billion in net revenues, with smoke-free products accounting for 42% of PMI's Q1 2025 total net revenues.
The company's leading brands IQOS and ZYN marked their 10-year anniversaries in 2024. As of December 31, 2024, PMI's smoke-free products were available in 95 markets and used by 38.6 million adults globally. PMI has invested over $14 billion since 2008 in developing and commercializing smoke-free products. The meeting saw approximately 82% shareholder participation, with shareholders electing 11 directors and approving executive compensation and auditor selection.
Philip Morris International (PMI) has announced its 2025 Virtual Annual Meeting of Shareholders, scheduled for May 7, 2025, at 9:00 a.m. ET. The virtual meeting will feature addresses from André Calantzopoulos, Chairman of the Board, and Jacek Olczak, Chief Executive Officer.
As of Q1 2025, PMI's smoke-free business represents 42% of total net revenues, with products available in 95 markets and approximately 38.6 million adult users worldwide. The company has invested over $14 billion since 2008 in developing smoke-free alternatives, focusing on scientific research and product innovation.
Key highlights:
- FDA authorization received for Swedish Match's General snus and ZYN nicotine pouches
- IQOS devices obtained Modified Risk Tobacco Product authorization
- Company expanding beyond tobacco into wellness and healthcare sectors
- Virtual meeting accessible at virtualshareholdermeeting.com/PM2025
Philip Morris International (NYSE: PM) CEO Jacek Olczak addressed global leaders at Semafor's World Economy Summit, highlighting regulatory disparities in smoke-free products access. The company revealed that approximately 20% of global smokers lack legal access to smoke-free alternatives, while cigarettes remain widely available.
Countries prohibiting smoke-free products, like Turkey and Brazil, show slower smoking rate declines, with Turkey's smoking prevalence remaining above 30% since 2014. Conversely, nations embracing smoke-free alternatives like Sweden, Japan, and the US have experienced significant decreases in cigarette sales and smoking rates.
PMI's smoke-free products are now available in 95 markets, used by 38.6 million adults globally, representing 42% of Q1 2025 total net revenues. The company has invested over $14 billion since 2008 in developing and scientifically validating smoke-free alternatives, with FDA authorizations for several products including IQOS devices and ZYN nicotine pouches.
Philip Morris International (PM) reported strong Q1 2025 results with reported diluted EPS growing 24.6% to $1.72 and adjusted diluted EPS increasing 12.7% to $1.69. The company's smoke-free business, representing 42% of total net revenues, showed impressive growth with shipment volumes up 14.4% and net revenues increasing 20.4% organically.
Key highlights include IQOS strengthening its position as the second-largest nicotine brand in markets where present, achieving approximately 77% volume share in the heat-not-burn category. ZYN nicotine pouches in the U.S. exceeded 200 million cans, representing 53% growth. Total PMI shipment volume increased 3.9% to 187.8 billion units.
The company raised its 2025 full-year forecast, now projecting adjusted diluted EPS of $7.36-$7.49, representing 12.0-14.0% growth versus 2024. PMI expects total shipment volume growth of up to 2% and organic net revenue growth of 6-8% for the full year.